In the cancer type multiple myeloma, the malignant cells differ significantly from normal cells regarding the layer of ...

Given the labyrinth of patent litigation ongoing between companies that were working on mRNA vaccines during the pandemic, a merger agreement between two of them – BioNTech and CureVac – raised ...